Dennis J. Slamon, MD, PhD | Authors

HER2 Testing and Correlation With Efficacy of Trastuzumab Therapy

November 01, 2002

As a result of the availability and clinical efficacy of trastuzumab (Herceptin), clinicians are now faced with a dilemma regarding the accurate identification of patients with HER2 overexpression. In the October 2002 issue of ONCOLOGY,